Nordic Nanovector Announces EU Patent Granted Covering the Use of Alpha37 |
| July 30, 2020 | July 2020 Bond Updates |
|
OSLO, Norway, July 30, 2020 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) is pleased to announce the grant of an EU patent covering the use of Alpha37 for the treatment of Chronic Lymphocytic Leukemia (CLL) and non-Hodgkin's lymphoma (NHL). Alpha37 is an investigational... |
| View more at: https://www.prnewswire.com:443/news-releases/nordic-nanovector-announces-eu-patent-granted-covering-the-use-of-alpha37-301102805.html |